James Shin
Stock Analyst at Deutsche Bank
(2.72)
# 2,128
Out of 5,111 analysts
23
Total ratings
60%
Success rate
20.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by James Shin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MRK Merck & Co. | Maintains: Hold | $110 → $111 | $100.26 | +10.71% | 3 | Nov 18, 2025 | |
| LLY Eli Lilly and Company | Maintains: Buy | $1,010 → $900 | $1,062.19 | -15.27% | 5 | Aug 11, 2025 | |
| IMTX Immatics | Initiates: Buy | $10 | $9.98 | +0.20% | 1 | May 28, 2025 | |
| GILD Gilead Sciences | Upgrades: Buy | $80 → $120 | $119.78 | +0.18% | 2 | Feb 18, 2025 | |
| AMGN Amgen | Reiterates: Hold | $310 → $305 | $325.31 | -6.24% | 2 | Aug 7, 2024 | |
| INCY Incyte | Maintains: Hold | $55 → $60 | $98.64 | -39.17% | 2 | Aug 1, 2024 | |
| BMY Bristol-Myers Squibb Company | Maintains: Hold | $53 → $45 | $54.29 | -17.11% | 3 | Jul 23, 2024 | |
| LEGN Legend Biotech | Initiates: Buy | $60 | $22.01 | +172.60% | 1 | May 23, 2024 | |
| ABBV AbbVie | Initiates: Hold | $150 | $227.45 | -34.05% | 1 | Nov 9, 2023 | |
| REGN Regeneron Pharmaceuticals | Initiates: Hold | $800 | $752.62 | +6.30% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.62 | +517.28% | 1 | Nov 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $120 | $9.93 | +1,108.46% | 1 | Nov 9, 2023 |
Merck & Co.
Nov 18, 2025
Maintains: Hold
Price Target: $110 → $111
Current: $100.26
Upside: +10.71%
Eli Lilly and Company
Aug 11, 2025
Maintains: Buy
Price Target: $1,010 → $900
Current: $1,062.19
Upside: -15.27%
Immatics
May 28, 2025
Initiates: Buy
Price Target: $10
Current: $9.98
Upside: +0.20%
Gilead Sciences
Feb 18, 2025
Upgrades: Buy
Price Target: $80 → $120
Current: $119.78
Upside: +0.18%
Amgen
Aug 7, 2024
Reiterates: Hold
Price Target: $310 → $305
Current: $325.31
Upside: -6.24%
Incyte
Aug 1, 2024
Maintains: Hold
Price Target: $55 → $60
Current: $98.64
Upside: -39.17%
Bristol-Myers Squibb Company
Jul 23, 2024
Maintains: Hold
Price Target: $53 → $45
Current: $54.29
Upside: -17.11%
Legend Biotech
May 23, 2024
Initiates: Buy
Price Target: $60
Current: $22.01
Upside: +172.60%
AbbVie
Nov 9, 2023
Initiates: Hold
Price Target: $150
Current: $227.45
Upside: -34.05%
Regeneron Pharmaceuticals
Nov 9, 2023
Initiates: Hold
Price Target: $800
Current: $752.62
Upside: +6.30%
Nov 9, 2023
Initiates: Buy
Price Target: $10
Current: $1.62
Upside: +517.28%
Nov 9, 2023
Initiates: Buy
Price Target: $120
Current: $9.93
Upside: +1,108.46%